马来酸噻吗洛尔对人脐静脉内皮细胞的VEGF传导通路表达的影响

doi:10.3969/j.issn.1005-4979.2018.04.005

摘要/Abstract

摘要： 目的：研究马来酸噻吗洛尔在人脐静脉内皮细胞（HUVEC）中血管生成信号传导通路的表达，以探讨这些药物作为治疗婴幼儿血管瘤的作用机制。方法：采用RT-PCR和Western blot检测蛋白激酶B（Akt）、细胞外调节蛋白激酶（ERK）、局部黏着斑激酶（FAK）和哺乳动物雷帕霉素靶蛋白（mTOR）的表达。应用SPSS17.0统计包进行数据分析。结果：RT-PCR检测发现，马来酸噻吗洛尔以剂量依赖的方式明显抑制血管内皮生长因子（vascular endothelial growth factor，VEGF）诱导的ERK、Akt、mTOR及FAK的mRNA表达；Western blot结果显示：马来酸噻吗洛尔以剂量依赖的方式明显抑制VEGF对磷酸化的细胞外调节蛋白激酶（p-ERK）、磷酸化蛋白激酶B（p-Akt）、磷酸化的哺乳动物雷帕霉素靶蛋白（p-mTOR）的调控。结论：马来酸噻吗洛尔可以通过抑制ERK、Akt、mTOR、FAK信号通路的表达，抑制血管瘤内皮细胞增殖和促进细胞凋亡，从而达到治疗婴幼儿血管瘤的目的。

关键词: 马来酸噻吗洛尔, 信号通路, 血管生长因子诱导

Abstract: Objective: The aim of this study was to investigate whether the expression of the vasculogenic signaling pathway in human umbilical vein endothelial cells (HUVEC)could be specifically targeted and inhibited by timolol maleate. Methods: RT-PCR and Western blot were used to detect the expression of Auto-ja Kuljetusalan Ty?觟ntekijliitto （Akt）, Extracellular regulated protein kinases （ERK）, focal adhesion kinase（FAK） and mammalian target of rapamycin （mTOR）, and SPSS17.0 statistical package was used to analyze the data. Results: RT-PCR detection showed that timolol maleate significantly inhibited the expression of vascular endothelial growth factor（VEGF） induced ERK, Akt, mTOR and FAK mRNA in a dose-dependent manner. Western blot results showed that timolol maleate significantly inhibited the regulation of p-ERK, p-Akt, and phosphorylation of VEGF in a dose-dependent manner. Conclusion: Timolol maleate can inhibit the expression of ERK, Akt, mTOR, FAK signaling pathway to inhibit the proliferation of vascular endothelial cells and promote cell apoptosis, so as to achieve the purpose of treating infantile hemangioma.

Key words: timolol maleate, signal transduction pathway, VEGF induction

中图分类号:

R856.78

隋琦佳，莘晓陶. 马来酸噻吗洛尔对人脐静脉内皮细胞的VEGF传导通路表达的影响[J]. 《口腔颌面外科杂志》, doi: 10.3969/j.issn.1005-4979.2018.04.005.

SUI Qi-jia, XIN Xiao-tao. Effect of Timolol Maleate on the Expression of Vascular Endothelial Growth Factor Induced Signal Transduction Pathway in Human Umbilical Vein Endothelial Cells[J]. 《Journal of Oral and Maxillofacial Surgery》, doi: 10.3969/j.issn.1005-4979.2018.04.005.

https://journal06.magtech.org.cn/Jweb_joms/CN/Y2018/V28/I4/204

参考文献

[1] Smith CJF, Jones KL, Johnson DL, et al. Risk of infantile hemangiomas in the offspring of women with autoimmune disease and the pathogenic implications of these lesions[J]. Am J Med Genet A, 2018, 176(3):570-577.

[2] Hubbard PA, Moody CL, Murali R. Allosteric modulation of Ras and the PI3K/AKT/mTOR pathway: emerging therapeutic opportunities[J]. Front Physiol, 2014, 5:478.

[3] Singh SS, Yap WN, Arfuso F, et al. Targeting the PI3K/Akt signaling pathway in gastric carcinoma: A reality for personalized medicine[J]? World J Gastroenterol, 2015, 21(43):12261-12273.

[4] Azijli K, Yuvaraj S, van Roosmalen I, et al. MAPK p38 and JNK have opposing activities on TRAIL-induced apoptosis activation in NSCLC H460 cells that involves RIP1 and caspase-8 and is mediated by Mcl-1[J]. Apoptosis, 2013, 18(7):851-860.

[5] 郝玉琴, 郑绘霞. MAPK/ERK信号传导通路在肿瘤治疗中作用机制的研究[J]. 中国麻风皮肤病杂志, 2012, 28(7):490-493.

[6] Kafousi M, Vrekoussis T, Tsentelierou E, et al. Immunohistochemical study of the angiogenetic network of VEGF, HIF1α, VEGFR-2 and endothelial nitric oxide synthase (eNOS) in human breast cancer[J]. Pathol Oncol Res, 2012, 18(1): 33-41.

[7] Bekhite MM, Finkensieper A, Binas S, et al. VEGF-mediated PI3K class IA and PKC signaling in cardiomyogenesis and vasculogenesis of mouse embryonic stem cells[J]. J Cell Sci, 2011, 124(Pt 11):1819-1830.

[8] Mehta RR, Yamada T, Taylor BN, et al. A cell penetrating peptide derived from azurin inhibits angiogenesis and tumor growth by inhibiting phosphorylation of VEGFR-2, FAK and Akt[J]. Angiogenesis, 2011, 14(3):355-369.

[9] 张杰, 张端莲, 陕声国. FAK在人皮肤血管瘤组织中的表达及意义[J]. 武汉大学学报(医学版), 2008, 29(5):620-622, 630, 707.

[10] Jinnin M, Medici D, Park L, et al. Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma[J]. Nat Med, 2008, 14(11):1236-1246.

[11] Jinnin M, Medici D, Park L, et al. Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma[J]. Nat Med, 2008, 14(11):1236-1246.

[12] Ji Y, Chen SY, Li K, et al. Signaling pathways in the development of infantile hemangioma[J]. J Hematol Oncol, 2014, 7:13.

[13] Ji Y, Chen S, Li K, et al. Upregulated autocrine vascular endothelial growth factor (VEGF)/VEGF receptor-2 loop prevents apoptosis in haemangioma-derived endothelial cells[J]. Br J Dermatol, 2014, 170(1):78-86.

[14] Franco M, Roswall P, Cortez E, et al. Pericytes promote endothelial cell survival through induction of autocrine VEGF-A signaling and Bcl-w expression[J]. Blood, 2011, 118(10):2906-2917.

[15] Sadaria MR, Yu JA, Meng XZ, et al. Secretory phospholipase A2 mediates human esophageal adenocarcinoma cell growth and proliferation via ERK 1/2 pathway[J]. Anticancer Res, 2013, 33(4):1337-1342.

[16] Zhang LF, Wu JH, Ling MT, et al. The role of the PI3K/Akt/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses[J]. Mol Cancer, 2015, 14: 87.

[17] 吕欣, 俞松, 刘远梅, 等. mTOR、p70S6K在体外培养血管瘤血管内皮细胞中的表达及意义[J]. 中华小儿外科杂志, 2012, 33(2):85-87.

[18] Liu JL, Mao ZY, Gallick GE, et al. AMPK/TSC2/mTOR-signaling intermediates are not necessary for LKB1-mediated nuclear retention of PTEN tumor suppressor[J]. Neuro-oncology, 2011, 13(2):184-194.

[19] Mihaylova MM, Shaw RJ. The AMPK signalling pathway coordinates cell growth, autophagy and metabolism[J]. Nat Cell Biol, 2011, 13(9):1016-1023.

[20] Xu YJ, Liu CX, Chen SJ, et al. Activation of AMPK and inactivation of Akt result in suppression of mTOR-mediat

选择文件类型/文献管理软件名称

选择包含的内容